The Chinese University of Hong Kong
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1963-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.cuhk.edu.hk
Immuno Cure Partners with PharmaJet to Advance HIV Therapeutic DNA Vaccine Using Needle-Free Delivery Technology
Immuno Cure and PharmaJet signed a collaboration agreement to evaluate the HIV therapeutic DNA vaccine ICVAX using PharmaJet's needle-free Tropis intradermal delivery system in clinical trials.
Cornerstone Robotics Secures $70M Series C to Challenge da Vinci's Surgical Robot Dominance
Cornerstone Robotics raised over $70 million in Series C funding led by EQT to accelerate commercialization of its Sentire endoscopic surgical system and challenge established players like da Vinci.
New Mainland Chinese Cancer Drug Shows Promising Results in Phase 1 Trial
A multinational study led by Chinese University of Hong Kong researchers found that D3S-001, a mainland-developed cancer drug, effectively treats tumors driven by KRAS-G12C gene mutations.
AI-Assisted Colonoscopy Boosts Adenoma Detection Rate by 40% in Junior Endoscopists
CU Medicine research demonstrates that AI-assisted colonoscopy significantly improves adenoma detection rates by 40% among junior endoscopists with less than three years of experience.
Microbiome Modulation with SIM01 Shows Promise for Long COVID Treatment in Randomized Trial
A randomized, triple-blind, placebo-controlled clinical trial by Chinese University of Hong Kong demonstrated that SIM01, an oral microencapsulated live bacteria formula, significantly improved long COVID symptoms compared to placebo.
D3Bio's Novel KRAS-G12C Inhibitor Shows Promising Results in Phase 1 Cancer Trial
A multinational study led by Chinese University researchers found that D3S-001, a mainland-developed KRAS-G12C inhibitor, demonstrated significant efficacy with over 70% of patients experiencing tumor shrinkage or disappearance.